V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicity
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (8), 731-740
- https://doi.org/10.1016/0024-3205(87)90300-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A parkinson-like neurologic deficit in primates is caused by a novel 4-substituted piperidineBrain Research, 1986
- 1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceEuropean Journal of Pharmacology, 1986
- The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease?Pharmaceutical Research, 1986
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Parkinson's disease in 65 pairs of twins and in a set of quadrupletsNeurology, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Cigarette smoking and Parkinson diseaseNeurology, 1980
- EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASEAmerican Journal of Epidemiology, 1971
- A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1American Journal of Epidemiology, 1968